‘Vaccine Manufacturing Has Its Own Share of Challenges’: Serum Institute of India CEO Adar Poonawalla in Exclusive Interview

One of the most critical challenges, Poonawalla told Firstpost, is to build a robust infrastructure that provides a seamless management of all operations. Pune-based SII manufactured the Covishield vaccine against Covid under a licensing agreement with British pharmaceutical giant AstraZeneca